Although the remaining anti-TNF therapies are considered off-label for uveitis, they are still used to control ocular inflammation associated with systemic diseases [21, 22] and are specially effective in Behçet’s disease [23, 24] and juvenile idiopathic arthritis [25]. Here, TNF is linked to uveitis.